BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3501243)

  • 1. Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas.
    Picker LJ; Brenner MB; Weiss LM; Smith SD; Warnke RA
    Am J Pathol; 1987 Dec; 129(3):434-40. PubMed ID: 3501243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
    Knowles DM
    Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a T cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas.
    Ng CS; Chan JK; Hui PK; Chan WC; Lo ST
    Am J Pathol; 1988 Aug; 132(2):365-71. PubMed ID: 2456701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.
    Gaulard P; Bourquelot P; Kanavaros P; Haioun C; Le Couedic JP; Divine M; Goossens M; Zafrani ES; Farcet JP; Reyes F
    Am J Pathol; 1990 Sep; 137(3):617-28. PubMed ID: 1698028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations.
    Picker LJ; Brenner MB; Michie S; Warnke RA
    Am J Pathol; 1988 Sep; 132(3):401-5. PubMed ID: 3261945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenotypic analysis of immature T-lineage cells].
    Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
    Rinsho Byori; 1993 Sep; 41(9):966-75. PubMed ID: 8254974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary gastric T-cell lymphoma of suppressor-cytotoxic (CD8+) phenotype: discordant expression of T-cell receptor subunit beta F1, CD7, and CD3 antigens.
    Banerjee D; Walton JC; Jory TA; Crukley C; Meek M
    Hum Pathol; 1990 Aug; 21(8):872-4. PubMed ID: 1696925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsets of CD3+ (T cell receptor alpha/beta or gamma/delta) and CD3- lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood.
    Jarry A; Cerf-Bensussan N; Brousse N; Selz F; Guy-Grand D
    Eur J Immunol; 1990 May; 20(5):1097-103. PubMed ID: 2141568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among expression, transcription and rearrangement of T-cell receptor beta gene in T-cell lymphomas.
    Kasai K; Kameya T; Ono M; Wada C; Kuwao S; Motoori T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):57-65. PubMed ID: 2163138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD2 expression correlates with proliferative capacity of alpha beta + or gamma delta + CD4-CD8- T cells in lpr mice.
    Budd RC; Russell JQ; van Houten N; Cooper SM; Yagita H; Wolfe J
    J Immunol; 1992 Feb; 148(4):1055-64. PubMed ID: 1346621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies.
    Su IJ; Balk SP; Kadin ME
    Am J Pathol; 1988 Aug; 132(2):192-8. PubMed ID: 2456698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.
    Shirai T; Abe M; Yagita H; Okumura K; Morse HC; Davidson WF
    J Immunol; 1990 May; 144(10):3756-61. PubMed ID: 1970592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.
    Quintanilla-Martinez L; Preffer F; Rubin D; Ferry JA; Harris NL
    Am J Clin Pathol; 1994 Oct; 102(4):483-9. PubMed ID: 7524302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
    Hori T; Spits H
    J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell malignancy in Richter's syndrome presenting as hyper IgM. Induction and characterization of a novel CD3+, CD4-, CD8+ T cell subset from phytohemagglutinin-stimulated patient's CD3+, CD4+, CD8+ leukemic T cells.
    Raziuddin S; Assaf HM; Teklu B
    Eur J Immunol; 1989 Mar; 19(3):469-74. PubMed ID: 2523311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant phenotypes in peripheral T cell lymphomas.
    Hastrup N; Ralfkiaer E; Pallesen G
    J Clin Pathol; 1989 Apr; 42(4):398-402. PubMed ID: 2469701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas.
    Weiss LM; Picker LJ; Grogan TM; Warnke RA; Sklar J
    Am J Pathol; 1988 Mar; 130(3):436-42. PubMed ID: 3258126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.